BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Drug Development

  FDA Slaps Clinical Hold on AstraZeneca PLC’s Phase III Head and Neck Cancer Program

  October 27, 2016

   · 

  2 min read
• 

  Job Trends

  Here’s Why Colorado’s Life Sciences Sector is Attractive to Job Seekers

  October 27, 2016

   · 

  8 min read
• Policy

  Endomag, European Device Makers Eye U.S. Amid Regulatory Changes

  October 27, 2016

   · 

  1 min read
• Genetown

  Fred Hutchinson Cancer Research Center Team Wants To Move Clean-Room Gene Therapy To Tabletop

  October 27, 2016

   · 

  1 min read
• BioCapital

  Charts Suggest 2017 Will Be The Year Of Biotech

  October 27, 2016

   · 

  1 min read
• Policy

  After “Female Viagra,” Muscular Dystrophy Drug, Will FDA Stand Firmer Against Pressure To Approve?

  October 27, 2016

   · 

  1 min read
• Genetown

  Novartis AG Is Challenging Biogen On Biogen’s Own Turf

  October 27, 2016

   · 

  1 min read
• 

  Drug Development

  Why Biogen’s Fate May Depend on Eli Lilly’s Alzheimer’s Data

  October 27, 2016

   · 

  3 min read
• BioCapital

  Donald Trump’s “Access Hollywood” Tape May Have Cost Biotech Investors $50 Billion

  October 27, 2016

   · 

  1 min read
• 

  Business

  Bristol-Myers Squibb to Revamp R&D and Streamline Operations After Opdivo Failure

  October 27, 2016

   · 

  3 min read